Compare CSBR & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | FSI |
|---|---|---|
| Founded | 1985 | 1991 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.7M | 71.3M |
| IPO Year | 2015 | 2000 |
| Metric | CSBR | FSI |
|---|---|---|
| Price | $5.90 | $6.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.2K | ★ 20.2K |
| Earning Date | 03-12-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 1.54% |
| EPS Growth | ★ 161.11 | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $2,900,000.00 | ★ $15,494,325.00 |
| Revenue This Year | $4.84 | $63.39 |
| Revenue Next Year | $11.51 | $43.77 |
| P/E Ratio | ★ N/A | $109.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $3.55 |
| 52 Week High | $9.63 | $11.48 |
| Indicator | CSBR | FSI |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 60.06 |
| Support Level | $5.50 | $6.35 |
| Resistance Level | $6.28 | $7.40 |
| Average True Range (ATR) | 0.27 | 0.34 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 34.40 | 56.52 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.